glp 1 compounded tirzepatide Personalized Treatment Compounded Tirzepatide (GLP-1/GIP) Injections |

This is a monumental shift in employers, taking the reins and controlling the benefit experience through flexibility, nimbleness and the ability to retain and attract top quality talent by offering world-class benefits by taking more of the onus on themselves, said Ford

Tirzepatide is a dual GIP and GLP-1 receptor agonist a newer class of injectable drug for Type 2 Diabetes and obesity

Rodent models of colitis and intestinal fistula have shown BPC-157 reduces inflammation and promotes mucosal healing via oral route

Adipose tissue is metabolically active and produces oestrogen through the aromatisation of androgens

Non-invasive and convenient: Administered as a weekly injection, it simplifies medication adherence and requires no lifestyle changes beyond dietary and exercise recommendations

At 20mg/ml concentration, 2.5mg equals 12.5 units on an insulin syringe